Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA

INTRODUCTION: US pneumococcal vaccination recommendations for adults aged 65 years or older recently changed, with options for either 20-valent pneumococcal conjugate vaccine (PCV20) or the combination of 15-valent conjugate vaccine (PCV15) followed by 23-valent polysaccharide vaccine (PPSV23) 1 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Kenneth J., Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334503/
https://www.ncbi.nlm.nih.gov/pubmed/35831685
http://dx.doi.org/10.1007/s40121-022-00669-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334503/
https://www.ncbi.nlm.nih.gov/pubmed/35831685
http://dx.doi.org/10.1007/s40121-022-00669-x

Ejemplares similares